Amoxicillin-Clavulanate

• Bacterial Sinusitis
• Ear Infections (Otitis Media)
• Skin and Soft Tissue Infections
• Lower Respiratory Tract Infections

Amoxicillin-clavulanate, marketed primarily as Augmentin, is a broad-spectrum oral antibiotic that pairs the aminopenicillin amoxicillin with the beta-lactamase inhibitor clavulanic acid. The combination is used in primary care for community-acquired infections in which beta-lactamase-producing organisms are likely or proven, including acute bacterial sinusitis after failure of first-line therapy, animal and human bite wounds, complicated otitis media, and selected lower respiratory and urinary tract infections. Pairing it with a beta-lactamase inhibitor extends the drug's reach to organisms that would otherwise inactivate plain amoxicillin, while preserving the favorable safety profile, predictable pharmacokinetics, and oral bioavailability that have made amoxicillin a cornerstone of outpatient antibiotic therapy for half a century.

Mechanism of Action

Amoxicillin binds to bacterial penicillin-binding proteins (PBPs) and inhibits transpeptidation, the final cross-linking step of peptidoglycan cell wall synthesis. The resulting structural defect leads to autolysis and bacterial death, particularly during active growth and division, which is why beta-lactam efficacy is time-dependent — the duration above the minimum inhibitory concentration matters more than peak levels. Many clinically important pathogens — including beta-lactamase-producing strains of Haemophilus influenzae, Moraxella catarrhalis, methicillin-susceptible Staphylococcus aureus, and many anaerobes such as Bacteroides fragilis — produce enzymes that hydrolyze the beta-lactam ring before it can reach its target. Clavulanic acid is itself a weak antibiotic with minimal intrinsic activity, but it binds irreversibly to many of these beta-lactamases, sacrificing itself to protect amoxicillin. The pairing restores activity against organisms that would otherwise be resistant. Notably, the combination does not cover methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, atypical respiratory pathogens such as Mycoplasma and Chlamydophila, or extended-spectrum beta-lactamase (ESBL) producing Enterobacterales. The FDA prescribing information details the spectrum, pharmacokinetics, and tissue penetration in full.

Clinical Use

In primary care, amoxicillin-clavulanate is most often selected for acute bacterial sinusitis when IDSA guidelines favor coverage of beta-lactamase producers — typically symptoms persisting beyond 10 days, severe presentation with high fever, or worsening after initial improvement (so-called double sickening). It is the regimen of choice for human and animal bite wounds, where Pasteurella multocida (cats), Capnocytophaga (dogs), Eikenella corrodens (humans), and oral anaerobes coexist, and for skin infection involving polymicrobial flora such as diabetic foot infections without osteomyelitis. It is also reasonable for selected cases of recurrent acute otitis media in children who have received amoxicillin within the prior month, and for community-acquired pneumonia in outpatients with comorbidities, prior antibiotic exposure, or a high local prevalence of resistant pneumococcus. For uncomplicated cystitis (urinary-tract-infection), narrower agents such as nitrofurantoin or trimethoprim-sulfamethoxazole are typically preferred over amoxicillin-clavulanate because of better bladder concentration and lower collateral damage to gut flora. When the suspected pathogen is sensitive, plain amoxicillin or cephalexin may suffice and is associated with less diarrhea and lower hepatotoxic risk; alternatives like azithromycin, doxycycline, cefdinir, or levofloxacin are chosen based on syndrome, allergy history, and local resistance. Choosing the narrowest effective agent is consistent with CDC antibiotic stewardship guidance and helps preserve future options for the individual patient and the community.

How to Take It

Take each dose at the start of a meal — food improves absorption of the clavulanate component, increases peak amoxicillin levels modestly, and substantially reduces nausea and diarrhea. Tablets and oral suspension are not interchangeable on a milligram-for-milligram basis because the ratio of amoxicillin to clavulanate differs across formulations; always use the strength your prescription specifies rather than substituting two lower-strength tablets, which can deliver an excessive clavulanate load and provoke severe diarrhea. The 875 mg twice-daily and 500 mg three-times-daily regimens are the most common adult doses. Reconstituted suspension must be refrigerated, shaken well before each dose, and discarded after 10 days. If you miss a dose, take it as soon as you remember unless the next dose is within two hours; do not double up. Complete the full course even if you feel better within 48–72 hours, which is when most patients notice improvement. Persistent fever or worsening symptoms after three days warrants reassessment for resistant organisms, complications such as abscess, or an alternative diagnosis. Avoid antacids within two hours of dosing, and consider a probiotic such as Saccharomyces boulardii or a multi-strain Lactobacillus product to reduce diarrhea risk during and for a few days after the course.

Monitoring and Follow-Up

Routine laboratory monitoring is not required for short courses in healthy outpatients. For courses longer than 10–14 days, in older adults, or in patients with prior hepatic events, a baseline and follow-up comprehensive metabolic panel — including ALT, AST, alkaline phosphatase, and bilirubin — is reasonable. Cholestatic hepatitis from amoxicillin-clavulanate can appear up to six weeks after the last dose and is more common in men over 55 and with repeated courses; the risk is roughly six times that of plain amoxicillin. Patients on warfarin should have an INR checked within the first week, as antibiotic-induced changes in gut flora can potentiate anticoagulation by reducing vitamin K production. Patients on combined oral contraceptives should consider a backup method during therapy and for seven days afterward, although the magnitude of interaction is debated. Our understanding-blood-work-lab-panels overview helps put these results in context. Any new diarrhea — especially if watery, frequent, accompanied by fever, or persistent more than two days after stopping the antibiotic — should prompt evaluation for Clostridioides difficile, which can develop weeks after exposure. A repeat clinical evaluation at the end of treatment is appropriate for sinusitis, pneumonia, and complicated infections to confirm resolution.

Special Populations

Amoxicillin-clavulanate is generally considered compatible with pregnancy and lactation when clinically indicated; only trace amounts appear in breast milk and there is reassuring observational experience. In renal impairment, the dose interval must be extended once creatinine clearance falls below 30 mL/min, and the 875 mg tablet should not be used in this setting because of its disproportionately high clavulanate load relative to the lower amoxicillin allowance. Older adults are at higher baseline risk for hepatotoxicity and for delirium with high-dose courses. Pediatric dosing is weight-based on the amoxicillin component, typically 25–45 mg/kg/day divided every 8–12 hours, with the higher dose used for acute otitis media in regions with significant penicillin-non-susceptible Streptococcus pneumoniae. Patients with a documented severe penicillin allergy — particularly anaphylaxis, angioedema, or Stevens–Johnson syndrome — should not receive this drug; those with mild, remote, non-IgE rashes can often be safely de-labeled after structured allergy assessment, opening the door to first-line therapy and avoiding the higher cost and collateral damage of broader alternatives. Cross-reactivity with cephalosporins is low (under 2%) when the side-chain structures differ.

Drug Interactions and Practical Counseling

While a separate structured drug interactions section accompanies this page, several pragmatic counseling points come up in clinic. Probenecid increases amoxicillin levels by reducing renal tubular secretion and is occasionally used intentionally in difficult infections. Allopurinol increases the rate of skin rash, although the rash is usually maculopapular rather than dangerous. Methotrexate clearance can be reduced, raising toxicity risk in rheumatology patients. Live oral typhoid vaccine should be deferred until at least 24 hours after the last antibiotic dose. Patients should be reminded that antibiotics do not treat viral infections — most upper respiratory infections, sore throats, and sinus pressure in the first 7–10 days are viral and self-limited, and unnecessary antibiotic courses contribute to resistance. The aafp.org guidance on appropriate antibiotic use is a helpful patient-facing reference.

Resistance and Stewardship Context

Resistance to amoxicillin-clavulanate is rising in some Enterobacterales because of inducible AmpC enzymes and porin mutations, even in organisms that test susceptible by automated systems. For prolonged courses or relapsed infections, repeat culture is helpful. Avoid using this antibiotic for asymptomatic bacteriuria except in pregnancy or before urologic procedures, and avoid prophylactic use for upper respiratory complaints. Document allergies precisely — "penicillin allergy" without details locks patients out of first-line therapy for life. A structured penicillin allergy assessment can de-label the majority of patients who report childhood rash and broaden their future options. The antibiotic-resistance-guide article gives patients an accessible primer on why these choices matter.

When to Contact Your Doctor

Call promptly for any new rash with mucosal involvement (mouth, eyes, genitals) or skin peeling, facial swelling or trouble breathing, jaundice or dark urine, persistent or bloody diarrhea, severe abdominal pain, fever returning after initial improvement, or unexplained bruising. Seek emergency care for hives with throat tightness, wheezing, or lightheadedness, which can signal anaphylaxis. Joint swelling, dark-colored stools, or seizure activity (rare, but reported with very high doses or renal impairment) also warrant urgent evaluation.

If you have questions about whether amoxicillin-clavulanate is the right choice for your infection, or if you are struggling with side effects or wondering about a possible penicillin allergy in your record, contact us or schedule a visit so we can review your symptoms, allergy history, and prior antibiotic exposures together and tailor the most appropriate regimen.